Marker Therapeutics Ownership | Who Owns Marker Therapeutics?


OverviewForecastRevenueFinancialsChart

Marker Therapeutics Ownership Summary


Marker Therapeutics is owned by 30.43% institutional investors, 7.08% insiders, and 62.49% retail investors. Nea management company is the largest institutional shareholder, holding 14.64% of MRKR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.61% of its assets in Marker Therapeutics shares.

MRKR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMarker Therapeutics30.43%7.08%62.49%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Nea management company1.63M14.64%$2.49M
Blue owl capital lp554.25K4.99%$848.00K
Aisling capital management lp325.37K2.93%$497.82K
Alyeska investment group213.02K1.92%$325.92K
Matrix asset advisors inc/ny15.00K0.14%$22.95K
Raymond james financial9.52K0.09%$14.56K
Riggs asset managment1.20K0.01%$1.84K
Blackrock funding, inc. /de992.000.01%$1.52K
Hilltop national bank73.000.00%$112.00
Versant capital management15.000.00%$23.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Blue owl capital lp554.25K0.27%$848.00K
Nea management company1.63M0.19%$2.49M
Aisling capital management lp325.37K0.14%$497.82K
Matrix asset advisors inc/ny15.00K0.00%$22.95K
Alyeska investment group213.02K0.00%$325.92K
Riggs asset managment1.20K0.00%$1.84K
Blackrock funding, inc. /de992.00-$1.52K
Raymond james financial9.52K-$14.56K
Ar asset management---
Versant capital management15.00-$23.00

Top Buyers

HolderShares% AssetsChange
Raymond james financial9.52K-9.52K
Hilltop national bank73.00-73.00
Versant capital management15.00--
Matrix asset advisors inc/ny15.00K0.00%-
Blue owl capital lp554.25K0.27%-

Top Sellers

HolderShares% AssetsChange
Hudson bay capital management lp---499.73K
Ar asset management---73.70K
Alyeska investment group213.02K0.00%-48.76K
Squarepoint ops---43.30K
Blackrock funding, inc. /de992.00--15.28K

New Positions

HolderShares% AssetsChangeValue
Raymond james financial9.52K-9.52K$14.56K
Hilltop national bank73.00-73.00$112.00

Sold Out

HolderChange
Squarepoint ops-43.30K
Ar asset management-73.70K
Hudson bay capital management lp-499.73K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202530-3.23%3,379,937-17.03%302.26%9-25.00%716.67%
Mar 31, 20251-73,700--97.29%----
Dec 31, 20241-73,700--121.08%--100.00%--
Sep 30, 20241-73,7004.24%-130.95%1---
Jun 30, 20241-70,700--125.86%----

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv181.72K1.61%-3.97K
Vanguard US Total Market Shares ETF153.47K1.43%-
Vanguard Institutional Extnd Mkt Idx Tr88.27K0.78%1.13K
Fidelity Extended Market Index47.74K0.42%-
WEALTHGATE Biotech Aggressive Fund I25.44K0.29%-
Vifag 2002 SICAV30.00K0.28%-
DFA US Small Cap I15.90K0.14%-
Fidelity Series Total Market Index13.89K0.12%-
Fidelity Total Market Index12.81K0.11%-
iShares Micro-Cap ETF12.60K0.11%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 23, 2024ELMS STEVE-Buy$35.47K
Dec 23, 2024New Enterprise Associates 16, L.P.-Buy$1.77M
Mar 16, 2021Eansor Norman David-Buy$249.99K
May 18, 2021Wasserman Frederick Gerald-Buy$24.10K
Mar 16, 2021Walker Paul Edward-Buy$10.00M

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q42-
2023 Q2--
2023 Q1--
2022 Q2--

MRKR Ownership FAQ


Who Owns Marker Therapeutics?

Marker Therapeutics shareholders are primarily institutional investors at 30.43%, followed by 7.08% insiders and 62.49% retail investors. The average institutional ownership in Marker Therapeutics's industry, Biotech Stocks , is 306.59%, which Marker Therapeutics falls below.

Who owns the most shares of Marker Therapeutics?

Marker Therapeutics’s largest shareholders are Nea management company (1.63M shares, 14.64%), Blue owl capital lp (554.25K shares, 4.99%), and Aisling capital management lp (325.37K shares, 2.93%). Together, they hold 22.56% of Marker Therapeutics’s total shares outstanding.

Does Blackrock own Marker Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Marker Therapeutics.

Who is Marker Therapeutics’s biggest shareholder by percentage of total assets invested?

Blue owl capital lp is Marker Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.27% of its assets in 554.25K Marker Therapeutics shares, valued at 848K$.

Who is the top mutual fund holder of Marker Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Marker Therapeutics shares, with 1.61% of its total shares outstanding invested in 181.72K Marker Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools